Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin nasal spray pretreatment for postoperative acute stress disorder after accidental fracture surgery
ChiCTR2400082612Phase 4Not yet recruiting
- Sponsor
- General Hospital of Western Theater Command of PLA
- Start
- Apr 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised trial of oxytocin in acute stress disorder (ASD) and post-traumatic stress disorder (PTSD) (2 arms), sponsored by General Hospital of Western Theater Command of PLA. Primary endpoint: SAS-RQ score. Planned start Apr 2024; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
acute stress disorder (ASD)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on ChiCTR2400082612.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082612.